Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Antitumor agent MSC-1936369B shows safety in phase I trial

June 9, 2010

Arbaclofen placarbil improves sleep quality in PPI-responsive GERD

June 9, 2010

Two placebo-controlled trials show safety of CX-157

June 9, 2010

Fast-dissolving desmopressin is safe in adults with nocturia

June 9, 2010

Irinotecan/S-1 active in 5-FU-resistant bladder cancer cell lines

June 9, 2010

H4 receptor antagonist UR-63325 yields favorable first-in-human data

June 8, 2010

Phase I trial data presented on GSK-923295 in solid tumors

June 8, 2010

MDX-1097 is evaluated in phase I trial in multiple myeloma

June 8, 2010

Aclidinium bromide shows preliminary efficacy in COPD

June 8, 2010

Tirofiban shows safety/preliminary efficacy in BAO and stroke

June 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...